期刊文献+

阿司匹林对胰腺癌细胞上皮间质转化和吉西他滨耐药性的影响 被引量:1

Effects of aspirin on epithelial mesenchymal transition and gemcitabine resistance of human pancreatic cancer cells
原文传递
导出
摘要 目的探讨阿司匹林对人胰腺癌细胞上皮间质转化(EMT)和吉西他滨耐药性的影响。方法应用MTT法检测阿司匹林(0、1、2、5、10mmol/L)对三种胰腺癌细胞(SW1990、PATU-8988、PANC-1)生存率的影响以及阿司匹林(2mmol/L)与吉西他滨(0.05mg/L)联合用药对SW1990细胞增殖的影响。平板克隆实验检测药物对克隆形成能力的影响;流式细胞术检测细胞凋亡情况;细胞划痕实验观察细胞的迁移能力;Western blot检测凋亡相关蛋白及EMT相关蛋白表达水平。结果(1)与对照组相比,低浓度阿司匹林(1、2mmol/L)对PATU-8988、PANC-1有生长抑制作用(P<0.05、P<0.01);高浓度阿司匹林(5、10mmol/L)对SW1990、PATU-8988、PANC-1均有较明显的生长抑制作用(P<0.05、P<0.01)。(2)与单药组相比,联合用药组中SW1990细胞增殖率显著降低,克隆形成率显著降低,凋亡率显著升高(P<0.05),细胞中的Bcl-2蛋白表达水平显著降低。(3)与单药组相比,联合用药组细胞迁移率显著降低,细胞中的EMT相关蛋白E-钙黏蛋白表达显著升高,波形蛋白表达显著降低。结论阿司匹林有抑制胰腺癌细胞增殖的作用,并且能增强细胞对吉西他滨的敏感性,同时逆转胰腺癌细胞EMT。 Objective To investigate the effects of aspirin on the epithelial mesenchymal transition and gemcitabine resistance of human pancreatic cancer cells.Methods Three kinds of human pancreatic cancer cell lines SW1990,PATU-8988 and PANC-1were treated with aspirin in different concentrations of 0,1,2,5and 10mmol/L,respectively.The SW1990 cells were treated with combined aspirin 2mmol/L and gemcitabine 0.05mg/L.The inhibition of cell proliferation was detected by MTT assay.Clonogenic assay was used to detect the proliferation ability.Wound healing assay was used to observe the migration capability.Flow cytometry was used to detect the apoptosis and Western blot was used to detect the expressions of the proteins related to EMT and apoptosis.Results Compared with the blank control group,the low dose(1,2mmol/L)of aspirin inhibited the proliferation of PATU-8988 and PANC-1(P0.05),the high dose(5,10mmol/L)of aspirin inhibited the proliferation of the three kinds of human pancreatic cancer cell lines(P0.05).Compared with using aspirin or gemcitabine alone,combined use of aspirin and gemcitabine could reduce the SW1990 cell proliferation rate and clone formation rate,increase the apoptotic rate(P0.05),decrease the expression of Bcl-2.Compared with using aspirin or gemcitabine alone,combined use of aspirin and gemcitabine could reduce the cell migration rate,increase the expression of E-cadherin,reduce the expression of Vimentin,which were related with the epithelial mesenchymal transition.Conclusion Aspirin may inhibit the proliferation of pancreatic cancer cell,enhance its sensitivity to gemcitabine,and reverse the epithelial mesenchymal transition of the pancreatic cancer cells.
出处 《江苏医药》 CAS 北大核心 2014年第17期1994-1997,I0001,共5页 Jiangsu Medical Journal
关键词 胰腺癌 阿司匹林 上皮间质转化 吉西他滨 Pancreatic cancer Aspirin Epithelial mesenchymal transition Gemcitabine
  • 相关文献

参考文献12

  • 1Cui J,Jiang W,Wang S,et al.Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer[J].Curr Pharm Des,2012,18(17):2464-2471.
  • 2Reddy LH,Marque PE,Dubernet C,et al.Preclinical toxicology(subacute and acute)and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine[J].J Pharmacol Exp Ther,2008,325(2):484-490.
  • 3Siegel R,Naishadham D,Jemal A.Cancer statistics for Hispanics/Latinos,2012[J].CA Cancer J Clin,2012,62(5):283-298.
  • 4Ghosh N,Chaki R,Mandal V,et al.COX-2as a target for cancer chemotherapy[J].Pharmacol Rep,2010,62(2):233-244.
  • 5Jacobs EJ,Newton CC,Gapstur SM,et al.Daily aspirin use and cancer mortality in a large US cohort[J].J Natl Cancer Inst,2012,104(16):1208-1217.
  • 6Hu LX,Du YY,Zhang Y,et al.Synergistic effects of exemestane and aspirin on MCF-7human breast cancer cells[J].Asian Pac J Cancer Prev,2012,13(11):5903-5908.
  • 7Pan JJ,Yang MH.The role of epithelial-mesenchymal transition in pancreatic cancer[J].J Gastrointest Oncol,2011,2(3):151-156.
  • 8Hotz HG,Hotz B,Buhr HJ.Genes associated with epithelialmesenchymal transition:possible therapeutic targets in ductal pancreatic adenocarcinoma[J]?Anticancer Agents Med Chem,2011,11(5):448-454.
  • 9Yang AD,Fan F,Camp ER,et al.Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines[J].Clin Cancer Res,2006,12(14Pt 1):4147-4153.
  • 10Chang TH,Tsai MF,Su KY,et al.Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor[J].Am J Respir Crit Care Med,2011,183(8):1071-1079.

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部